Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil Salles

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hypertension (Dallas, Tex. : 1979)|October 28, 2009
Efficacy of spironolactone therapy in patients with true resistant hypertensionFabio de Souza, Elizabeth Muxfeldt, Roberto Fiszman, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2005
Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertensionGil Salles, Sharon Leocádio, Katia Bloch, et al.
Circulation|July 2, 2003
Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up studyGil Salles, Sergio Xavier, Andrea Sousa, et al.
Hypertension (Dallas, Tex. : 1979)|August 2, 2006
Importance of the electrocardiographic strain pattern in patients with resistant hypertensionGil Salles, Claudia Cardoso, Armando R Nogueira, et al.
International Journal of Cardiology|April 29, 2015
Development of a risk score to predict sudden death in patients with Chaga's heart diseaseAdriana Campos Junqueira de Souza, Gil Salles, Alejandro Marcel Hasslocher-Moreno, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2025
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hypertension (Dallas, Tex. : 1979)|October 28, 2009
Efficacy of spironolactone therapy in patients with true resistant hypertensionFabio de Souza, Elizabeth Muxfeldt, Roberto Fiszman, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2005
Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertensionGil Salles, Sharon Leocádio, Katia Bloch, et al.
Circulation|July 2, 2003
Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up studyGil Salles, Sergio Xavier, Andrea Sousa, et al.
Hypertension (Dallas, Tex. : 1979)|August 2, 2006
Importance of the electrocardiographic strain pattern in patients with resistant hypertensionGil Salles, Claudia Cardoso, Armando R Nogueira, et al.
International Journal of Cardiology|April 29, 2015
Development of a risk score to predict sudden death in patients with Chaga's heart diseaseAdriana Campos Junqueira de Souza, Gil Salles, Alejandro Marcel Hasslocher-Moreno, et al.
Alimentary Pharmacology & Therapeutics|October 28, 2025
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Kaleb Tesfai, Luis Antonio Díaz, Juan Pablo Arab, et al.
Pageof 1